Loading fund information
Price chart (1D to 10Y)
Licensed market data — shown to members, not published to the open web.
The fund’s disclosed portfolio, not an index membership list. Showing the largest 21 positions. The ten largest identified positions carry 60.2% of the portfolio.
| # | Holding | Sector | Country | Weight | Filed value |
|---|---|---|---|---|---|
| 1 | Novo Nordisk A/S NVO | Healthcare | Denmark | 9.75% | $425.75K |
| 2 | Eli Lilly & Co LLY | Healthcare | United States | 9.26% | $404.20K |
| 3 | Scholar Rock Holding Corp SRRK | Healthcare | United States | 5.71% | $249.20K |
| 4 | Hims & Hers Health Inc HIMS | Healthcare | United States | 5.57% | $243.14K |
| 5 | Viking Therapeutics Inc VKTX | Healthcare | United States | 5.48% | $239.59K |
| 6 | AbbVie Inc ABBV | Healthcare | United States | 5.19% | $226.72K |
Source: SEC filings. Information and analytics, not investment advice.
| 7 |
| Arrowhead Pharmaceuticals Inc ARWR |
| Healthcare |
| United States |
| 5.08% |
| $221.87K |
| 8 | Innovent Biologics Inc | — | China | 5.00% | $218.23K |
| 9 | Amgen Inc AMGN | Healthcare | United States | 4.58% | $199.89K |
| 10 | Chugai Pharmaceutical Co Ltd | — | Japan | 4.56% | $199.33K |
| 11 | Merck & Co Inc MRK | Healthcare | United States | 4.56% | $199.17K |
| 12 | AstraZeneca PLC AZN | Healthcare | United Kingdom | 4.55% | $198.91K |
| 13 | Roche Holding AG | — | Switzerland | 4.51% | $197.20K |
| 14 | Regeneron Pharmaceuticals Inc REGN | Healthcare | United States | 4.48% | $195.79K |
| 15 | CSPC Pharmaceutical Group Ltd | — | China | 4.48% | $195.53K |
| 16 | Pfizer Inc PFE | Healthcare | United States | 4.39% | $191.60K |
| 17 | Zealand Pharma A/S | — | Denmark | 3.48% | $152.10K |
| 18 | Kailera Therapeutics Inc KLRA | Healthcare | United States | 2.45% | $107.15K |
| 19 | Jiangsu Hengrui Pharmaceutical | — | China | 2.26% | $98.85K |
| 20 | Invesco Government & Agency Po | — | United States | 2.01% | $87.84K |
| 21 | Hanmi Pharm Co Ltd | — | South Korea | 2.00% | $87.48K |